Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Empresas ICA SA (ADR) (ICA): Emerging-Market Growth at Discount Domestic Prices

It’s been said plenty of times that our neighbor to the south is home to a burgeoning, debt-light economy that offers emerging-market growth with an element of domestic risk and valuation. China is very much “last season” when it comes to manufacturing, and Mexico offers a fantastic answer, with geographical superiority and an eager work force. One company based in Mexico, Empresas ICA SA (ADR) (NYSE:ICA), is a heavy-construction firm with a market cap of $1 billion that was as recently as April worth nearly $2 billion. The causes for the haircut includes a collapsed deal and lousy first-quarter earnings. But with a strong outlook for Mexican infrastructure spending, and an apparent case of market negligence, Empresas ICA SA (ADR) (NYSE:ICA) might be an undervalued pick with substantial upside potential.

Grow Mexico
Recently elected Mexican President Enrique Pena Nieto holds infrastructure investments as a top priority for his administration. In fact, his proposed 5% of GDP plan represents one of the largest national undertakings in more than 20 years. Using current projections (recently revised down) of 3.5% GDP growth, Mexico should have a GDP of $1.196 trillion. Five percent of that amount, $59.79 billion, is theoretically allocated toward infrastructure improvements — 12% of which is directly allocated to transportation enchancements.

Empresas ICA SA (ADR) (NYSE:ICA) is the largest construction company in Mexico. Now, that doesn’t mean $7 billion will be funneled into the company this year, but it’s useful as an illustration of the macro environment supporting Empresas. Even more so, considering the company’s stock price was nearly cut in half over a period of eight weeks.

The Mexican government plans on a buildout of a new rail system for 1,000 miles, thousands of miles of road improvements, new airports, and ports.

Empresas ICA SA (ADR) (NYSE:ICA) showed some poor numbers in its first-quarter earnings, with a 31% drop in revenue, year over year. The company was also set to sell its homebuilding segment to Servicios Corporativos Javer, a huge private builder — sending the stock down another 10 points.

Macro events, of course, can’t dictate the entirety of an investment thesis. Empresas ICA SA (ADR) (NYSE:ICA) has a so-so balance sheet, with more than $3.2 billion in long-term debt and just $608 million in cash. On the flip side, the company generated nearly $387 million in free cash flow last year, indicating that it should have little trouble meeting creditor payments.

In addition to its operating cash flows, the company recently sold its nearly 19% stake in Red de Carreteras de Occidente — the rights holder and operator to nearly 500 miles of highway in Mexico. The deal will give the company roughly $380 million as part of its asset recycling process.

For a quick comparison, take a look at U.S.-based MasTec, Inc. (NYSE:MTZ), which trades at just under 13.75 times forward earnings yet holds a more conservative balance sheet and is a good bit larger at a market cap of $2.34 billion. While MasTec, Inc. (NYSE:MTZ) is building out its operations in Canada, Empresas offers potential outperformance by virtue of its market dominant position in Mexico.

Empresas ICA SA (ADR) (NYSE:ICA) appears to offer investors shares that are priced to move and a business that is set to grow.

The article Emerging-Market Growth at Discount Domestic Prices originally appeared on and is written by Michael Lewis.

Fool contributor Michael Lewis has no position in any stocks mentioned. The Motley Fool recommends and owns shares of MasTec.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!